TherapeuticsMD, Inc.

General ticker "TXMD" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - Specialty & Generic
  • Capitalization: $17.7M (TTM average)

TherapeuticsMD, Inc. follows the US Stock Market performance with the rate: 35.7%.

Estimated limits based on current volatility of 3.4%: low 1.95$, high 2.09$

Factors to consider:

  • Total employees count: 5 as of 1995
  • Price in estimated range
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [1.15$, 2.62$]
  • 2026-12-31 to 2027-12-31 estimated range: [1.04$, 2.40$]

Financial Metrics affecting the TXMD estimates:

  • Positive: with PPE of -33.3 at the end of fiscal year the price was neutral
  • Negative: negative Operating income
  • Positive: 6.59 < Operating cash flow per share per price, % of 12.51
  • Positive: Interest expense per share per price, % of 0 <= 0.01
  • Positive: -3.75 < Return on assets ratio (scaled to [-100,100]) of -1.70
  • Positive: Investing cash flow per share per price, % of 0 > -0.60
  • Positive: Inventory ratio change, % of 0 <= 0

Similar symbols

Short-term TXMD quotes

Long-term TXMD plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $1.30MM $1.76MM $3.02MM
Operating Expenses $9.82MM $6.52MM $7.41MM
Operating Income $-8.52MM $-4.76MM $-4.39MM
Non-Operating Income $0.78MM $2.42MM $3.74MM
Income(Loss) $-7.74MM $-2.34MM $-0.65MM
Taxes $-0.04MM $-0.03MM $0.00MM
Other Income(Loss) $-2.58MM $0.13MM $0.08MM
Net Income(Loss)* $-12.86MM $-2.18MM $-0.57MM
Stockholders Equity $29.29MM $27.37MM $26.88MM
Assets $43.31MM $38.82MM $37.66MM
Operating Cash Flow $-23.08MM $0.73MM $2.42MM
Capital expenditure $48.14MM $0.00MM $0.00MM
Investing Cash Flow $-25.06MM $0.00MM $0.00MM
Financing Cash Flow $3.15MM $0.00MM $0.00MM
Earnings Per Share** $-1.23 $-0.19 $-0.05

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.